A5091100115- Retinal Diseases and Treatments
- Retinal and Macular Surgery
- Retinal Imaging and Analysis
- Vascular Malformations Diagnosis and Treatment
- Neurological and metabolic disorders
- Intraocular Surgery and Lenses
- Cerebral Venous Sinus Thrombosis
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
Sankara Nethralaya
2022
To study the relevance of preoperative OCT predictors in large macular holes (MH) treated using inverted ILM peel technique.Prospective 95 patients undergoing vitrectomy for MH between January 2019 and December 2020 was performed by dividing into groups depending on various quantitative parameters indices such as base diameter (BD), hole form factor (HFF), index (MHI), (DHI), tractional (THI) minimal diameter, height, nasal temporal arm lengths. Depending upon duration symptoms, were divided...
Diabetic membranes are always a challenge for surgeon because of sticky nature and chances iatrogenic break while removing.To demonstrate safe reverse swiss roll technique to dissect diabetic vitreous membranes.Approaches techniques membrane dissection segmentation, delamination en-bloc using various types instruments illumination. With cutte, picks scissors, surgical steps traditionallu performed by classic lift shave technique. After identifying the plane, tissue is lifted then cut, which...
A 56-year-old female presented for a regular check-up. On examination, the best-corrected visual acuity in both eyes was 6/6. The anterior segment within normal limits. Fundus examination showed choroidal folds at macula eyes. Both fundus photo, optical coherence tomography (OCT), retro, autofluorescence (FAF), angiography (OCTA), and B-scan were done. Except axial length, which range of hypermetropia, i.e., 20.10 mm 20.30 mm, no other positive findings (like lesion on computed (CT)...
Purpose: To evaluate real-world outcomes with neovascular age-related macular degeneration (nAMD) in relation to anatomical success, visual outcomes, and safety of intravitreal brolucizumab (IVBr) injection at 1.5 years. Methods: Prospective, randomized, single-center study between December 2020 2022 that included 71 eyes 62 patients nAMD, who received IVBr. Patients were divided into three groups, i.e., naïve choroidal membrane (CNVM), switched therapy (st) CNVM, st polypoidal vasculopathy...